CYSTIC FIBROSIS ONE OUT OF EVERY 2, 500 BIRTHS IN THE UNITED STATES WILL BE DIAGNOSED WITH CYSTIC FIBROSIS. THIS FACT MAKES CYSTIC FIBROSIS ONE OF THE MOST COMMON GENETIC DISEASES IN THE NATION. ABOUT 30, 000 AMERICANS HAVE THE DISEASE, BUT EVEN THOUGH CYSTIC FIBROSIS IS THE NATIONS MOST COMMON GENETIC DISEASE THE MAJORITY OF AMERICANS KNOW LITTLE ABOUT IT. CYSTIC FIBROSIS IS RELATIVELY COMMON IN CALCASTION PEOPLE BUT RARE IN AFRICAN-AMERICAN. THE DISEASE IS VERY UNCOMMON IN MONGOLIANS. FIVE PERCENT OF THE POPULATION IN THE UNITED STATES ARE CARRIERS OF THE GENETIC DISEASE.
CYSTIC FIBROSIS, SOMETIMES CLASSIFIED AS MUCOVISCIDOSIS, IS A DISORDER IN WHICH THE EXCRORINE GLANDS SECRETE ABNORMALLY THICK MUCUS. THIS LEADS TO THE OBSTRUCTION OF THE PANCREAS AND CHRONIC INFECTIONS OF THE LUNGS, WHICH GENERALLY CAUSES DEATH IN CHILDHOOD OR EARLY ADULTHOOD. SOME MILDLY AFFECTED PATIENTS MAY SURVIVE LONGER. PATIENTS WITH PANCREATIC INSUFFICIENCY TAKE PANCREATIC ENZYMES WITH MEALS. THOSE WITH RESPIRATORY INFECTIONS ARE TREATED WITH ANTIBIOTICS, MOSTLY WITH AEROSOLS THAT RELIEVE CONSTRICTION OF THE AIRWAYS.
PHYSICAL THERAPY IS USED TO HELP PATIENTS COUGH UP THE OBSTRUCTING MUCUS. INTESTINAL OBSTRUCTION, WHICH OCCURS MOSTLY IN INFANCY, MAY REQUIRE SURGERY. IN 1989, RESEARCHERS FOND THE ABNORMAL GENE THAT CAUSES CYSTIC FIBROSIS. THIS GENE IS LOCATED ON CHROMOSOME 7. A PERSON WHO HAS TWO CYSTIC FIBROSIS GENES HAS THE DISEASE.
A PERSON THAT CARRIES ONE OF THE GENES DOES NOT HAVE THE GENETIC DISEASE, BUT IS A CARRIER. THE SYMPTOMS OF CYSTIC FIBROSIS SOMETIMES OCCUR IMMEDIATELY AFTER BIRTH. MUCUS SECRETIONS MAY APPEAR IN THE BABY’S INTESTINES, WHICH CAN CAUSE OBSTRUCTION IN THE INTESTINES. IN ALL CASES, THE CHILD WILL GAIN LITTLE WEIGHT RIGHT FROM BIRTH, BECAUSE THE PANCREAS IS NOT PRODUCING ENZYMES. LITTLE TO NO NUTRIENTS ARE ABSORBED IN THE CHILD’S SYSTEM.
The Essay on Cystic Fibrosis Disease Mucus Life
Cystic fibrosis is the most common autosomal recessive genetic disease of white Indo-Europeans (Caucasians). Three main systems are usually affected by cystic fibrosis. These include the lungs and respiratory tract, the digestive tract (especially the pancreas and intestines) and the sweat glands. The lungs will normally have a thick mucus line them in cases of cystic fibrosis which requires ...
A CHILD WITH CYSTIC FIBROSIS MAY HAVE REOCCURRING RESPIRATORY INFECTIONS, ALONG WITH COUGH AND FEVER. THIS MAY BEFORE SEVERE AND PERSISTENT THAT NORMAL THIS IS A RESULT OF THE THICK, STICKY MUCUS THAT WILL HOLD AND TRAP GERMS IN THE BRONCHIAL TUBES. IT SHOULD BE TAKEN IN TO CONSIDERATION THAT CHILDREN WITH CYSTIC FIBROSIS HAVE LARGE APPETITES AND EAT A GREAT DEAL. IN SPITE OF THEIR MALNUTRITION, THEY ART NOT IN PAIN AND DO NOT GENERALLY FEEL IT. EXTRACTS OF ANIMAL PANCREAS, IN POWDER OR GRANULE FORM, ARE PRESCRIBED TO REPLACE THE MISSING ENZYMES FROM THE PANCREAS, AND THE AMOUNT OF FAT IS DECREASED IN THE CHILD’S DIET. WITH THIS TREATMENT THE CHILD BEGINS TO GAIN WEIGHT.
TO KEEP THE LUNGS FREE OF AS MUCH MUCUS AS POSSIBLE, THE PATIENTS MAY NEED TO HAVE DAILY RESPIRATORY PHYSICAL THERAPY. ANY RESPIRATORY INFECTION THAT ARISE ARE TREATED WITH LARGE AMOUNTS OF ANTIBIOTICS. CYSTIC FIBROSIS CAN NOT YET BE CURED. ALTHOUGH THE IDENTIFICATION OF CHROMOSOME 7 HAS PAVED THE WAY FOR GENE THERAPY.
ANTIBIOTICS AND ENZYMES ARE NO TTHE ONLY TREATMENTS FOR CYSTIC FIBROSIS. ONE RELATIVELY NEW TREATMENT IS A BIOTECH DRUG THAT THINS THE MUCUS, WHICH HELPS THE LUNGS FUNCTION BETTER AND REDUCES THE RISK OF INFECTIONS. GENE THERAPY IS STILL IN EXPERIMENTAL STAGES.
